Dashboard
Manage Tickers

VRTX


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

vertex-pharmaceuticals-announces-fda-acceptance-of-nda-for-vanza-triple-therapy-with-priority-review-pdufa-target-date-set-for-january-2-2025-eu-marketing-authorization-application-also-validated-by-ema-for-cystic-fibrosis-treatment
Vertex Pharmaceuticals Announces FDA Accep...
07/02/2024 12:34:11

1000-invested-in-this-stock-15-years-ago-would-be-worth-14000-today
$1000 Invested In This Stock 15 Years Ago ...
07/01/2024 18:30:22

this-vertex-pharmaceuticals-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-thursday
This Vertex Pharmaceuticals Analyst Begins...
06/27/2024 12:41:40

redburn-atlantic-initiates-coverage-on-vertex-pharmaceuticals-with-buy-rating-announces-price-target-of-545
Redburn Atlantic Initiates Coverage On Ver...
06/27/2024 09:46:51

Redburn Atlantic analyst Steve Chesney initiates coverage on Vertex Pharmaceuticals (NASDAQ:VRTX) with a Buy rating and anno...

peering-into-vertex-pharmaceuticalss-recent-short-interest
Peering Into Vertex Pharmaceuticals's Rece...
06/26/2024 20:30:19

wells-fargo-maintains-overweight-on-vertex-pharmaceuticals-raises-price-target-to-555
Wells Fargo Maintains Overweight on Vertex...
06/24/2024 13:01:44

Wells Fargo analyst Mohit Bansal maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Overweight and raises the price targe...

vertex-pharmaceuticals-presents-new-data-from-phase-12-clinical-trial-of-vx-880-stem-cell-derived-islet-cell-therapy-for-type-1-diabetes-updated-results-on-12-patients-show-consistency-with-previous-findings-and-highlight-transformative-potential
Vertex Pharmaceuticals Presents New Data F...
06/21/2024 19:46:04

– All 12 patients who received the full dose of VX-880 as a single infusion demonstrated islet cell engraftment and glucose-res...

heres-how-much-you-would-have-made-owning-vertex-pharmaceuticals-stock-in-the-last-20-years
Here's How Much You Would Have Made Owning...
06/18/2024 19:30:29

13-analysts-have-this-to-say-about-vertex-pharmaceuticals
13 Analysts Have This To Say About Vertex ...
06/17/2024 18:00:16

argus-research-maintains-buy-on-vertex-pharmaceuticals-raises-price-target-to-550
Argus Research Maintains Buy on Vertex Pha...
06/17/2024 17:06:07

Argus Research analyst Jasper Hellweg maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Buy and raises the price target ...

nvidia-abbvie-vertex-pharmaceuticals-and-an-oil-giant-cnbcs-final-trades
Nvidia, AbbVie, Vertex Pharmaceuticals And...
06/17/2024 12:47:19

On CNBC's Halftime Report, Bryn Talkington picked NVIDIA, Jim Lebenthal chose Vertex Pharmaceuticals, Kevin Simpson named C...

Core News & Articles
CNBC Halftime Report Final Trades: NVIDIA,...
06/14/2024 17:00:47

vertex-reveals-long-term-data-on-casgevy-exagamglogene-autotemcel-at-eha-2024-congress
Vertex Reveals Long-Term Data On CASGEVY (...
06/14/2024 08:14:10

alphabet-to-rally-over-28-here-are-10-top-analyst-forecasts-for-tuesday
Alphabet To Rally Over 28%? Here Are 10 To...
06/11/2024 12:53:07

rbc-capital-maintains-sector-perform-on-vertex-pharmaceuticals-lowers-price-target-to-421
RBC Capital Maintains Sector Perform on Ve...
06/11/2024 11:36:19

RBC Capital analyst Brian Abrahams maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Sector Perform and lowers the price...

arcturus-inhaled-mrna-therapeutic-in-cystic-fibrosis-study-highlights-potential-amid-competitive-landscape-analyst
Arcturus' Inhaled mRNA Therapeutic In Cyst...
06/07/2024 18:44:44

Arcturus Therapeutics shared Phase 1 and Phase 1b trial results for ARCT-032, an inhaled mRNA therapeutic for cystic fibrosis, ...

vertex-to-present-new-data-demonstrating-significant-benefits-of-treatment-with-trikafta-at-the-ecfs-47th-european-cystic-fibrosis-conference-held-june-5-8-2024
Vertex To Present New Data Demonstrating S...
06/07/2024 16:03:01

- Results from a randomized, placebo-controlled study of TRIKAFTA® in people with cystic fibrosis with rare, non-F508del CFTR m...

1000-invested-in-vertex-pharmaceuticals-5-years-ago-would-be-worth-this-much-today
$1000 Invested In Vertex Pharmaceuticals 5...
06/05/2024 18:00:32

rbc-capital-reiterates-sector-perform-on-vertex-pharmaceuticals-maintains-424-price-target
RBC Capital Reiterates Sector Perform on V...
06/04/2024 13:50:18

RBC Capital analyst Brian Abrahams reiterates Vertex Pharmaceuticals (NASDAQ:VRTX) with a Sector Perform and maintains $424 ...

this-is-what-whales-are-betting-on-vertex-pharmaceuticals
This Is What Whales Are Betting On Vertex ...
06/03/2024 19:16:00

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)
07/23/2024 Fastly, Inc. (FSLY)
07/29/2024 Enphase Energy, Inc. (ENPH)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)